The largest database of trusted experimental protocols

Nextera dna exome

Manufactured by Illumina
Sourced in United States

The Nextera DNA exome is a library preparation kit designed for targeted sequencing of the human exome. It utilizes a transposon-based fragmentation and tagging technology to generate sequencing-ready libraries from genomic DNA samples. The core function of the Nextera DNA exome is to enable efficient and cost-effective capture and enrichment of the protein-coding regions of the human genome for downstream sequencing analysis.

Automatically generated - may contain errors

2 protocols using nextera dna exome

1

Whole Exome Sequencing Analysis of Family 489

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study, we analyzed the WES data from four affected and two unaffected members of family 489 (both parents, the proband, and three siblings; Figure 1a,b). Exome capture was performed using the Nextera Rapid Capture Enrichment kit (expanded; includes untranslated genomic regions; San Diego, CA, USA) from Illumina (Illumina Nextera DNA exome; San Diego, CA, USA), which covers ≥ 98% of RefSeq, CCD, and Ensemble coding content of genes. The captured exomes were sequenced using the Illumina HighSeq instrument with paired-end sequencing at the University of Nebraska Medical Center Genomics Core Facility. The high-quality sequencing data were mapped to the human reference genome (hg19) using the Burrows—Wheeler Aligner (BWA) and Genome Analysis Toolkit (GATK) best practices pipeline [36 (link),37 (link)]. The resulting VCF file was processed to identify coding and non-coding variants after removing low quality calls. Low-quality calls did not meet at least one of the following criteria: QUAL ≥ 50 (quality score), VQSLOD ≥ 0 (variant quality score log-odds of being a true variant versus being false based on the trained Gaussian mixture model), DP ≥ 5 (read depth) for all individuals in a family, and QD > 5 (quality by depth = QUAL score divided by allele depth).
+ Open protocol
+ Expand
2

Whole Exome Sequencing for Rare Disease Diagnosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole exome sequencing (WES) was carried out on genomic DNA extracted from peripheral blood by the Nextera DNA Exome (Illumina, San Diego, CA, USA) on a NextSeq550Dx sequencer (Illumina). Sequencing reads were aligned to the human reference genome (UCSC hg19) by BWA (v0.7.7-isis-1.0.2) (Illumina). Variant calling was performed by GATK Variant Caller (v1.6-23-gf0210b3). DNA variants were annotated by eVai v2.5 (EnGenome). Variants mapping in genes associated to the following Human Phenotype Ontology (HPO) phenotypes were prioritized and then filtered by MAF < 0.01 (GnomAD v2.1): HP0001249, 0001256, 0002187, 0002342, 0006887, 0006889, 0010864, 0012759. Filtered variants were classified according to ACMG-AMP criteria [8 (link)]. The most phenotype-fitting variant was confirmed by Sanger sequencing. Genomic DNA from both parents was analyzed for segregation analysis of the variant.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!